{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:30:46Z","timestamp":1790425846619,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,21]]},"DOI":"10.7759\/cureus.15149","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T13:21:17Z","timestamp":1621603277000},"source":"Crossref","is-referenced-by-count":10,"title":["Hematologic Findings in Pregnancy: A Guide for the Internist"],"prefix":"10.7759","author":[{"given":"Pooja","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Balanchivadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Recommendations to prevent and control iron deficiency in the United States. (n.d.). (1998). https.\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00051880.htm."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06223.x","article-title":"Anemia in pregnancy","volume":"900","author":"Sifakis S","year":"2000","unstructured":"Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci. 2000, 900:125-36. 10.1111\/j.1749-6632.2000.tb06223.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.02.007","article-title":"Thrombotic microangiopathies of pregnancy: differential diagnosis","volume":"12","author":"Gupta M","year":"2018","unstructured":"Gupta M, Feinberg BB, Burwick RM. Thrombotic microangiopathies of pregnancy: differential diagnosis. Pregnancy Hypertens. 2018, 12:29-34. 10.1016\/j.preghy.2018.02.007","journal-title":"Pregnancy Hypertens"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.232","article-title":"Congenital and acquired bleeding disorders in pregnancy","volume":"2016","author":"Gernsheimer TB","year":"2016","unstructured":"Gernsheimer TB. Congenital and acquired bleeding disorders in pregnancy. Hematology Am Soc Hematol Educ Program. 2016, 2016:232-5. 10.1182\/asheducation-2016.1.232","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/14767051003678234","article-title":"Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I - folate, vitamin B12, vitamin B6","volume":"23","author":"Simpson JL","year":"2010","unstructured":"Simpson JL, Bailey LB, Pietrzik K, Shane B, Holzgreve W. Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I - folate, vitamin B12, vitamin B6. J Matern Fetal Neonatal Med. 2010, 23:1323-43. 10.3109\/14767051003678234","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2015.2.10289","article-title":"The impact of maternal iron deficiency and iron deficiency anemia on child's health","volume":"36","author":"Abu-Ouf NM","year":"2015","unstructured":"Abu-Ouf NM, Jan MM. The impact of maternal iron deficiency and iron deficiency anemia on child's health. Saudi Med J. 2015, 36:146-9. 10.15537\/smj.2015.2.10289","journal-title":"Saudi Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0518-4","article-title":"Prepartum anaemia: prevention and treatment","volume":"87","author":"Milman N","year":"2008","unstructured":"Milman N. Prepartum anaemia: prevention and treatment. Ann Hematol. 2008, 87:949-59. 10.1007\/s00277-008-0518-4","journal-title":"Ann Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/72.1.257S","article-title":"Iron requirements in pregnancy and strategies to meet them","volume":"72","author":"Bothwell TH","year":"2000","unstructured":"Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr. 2000, 72:257S-64. 10.1093\/ajcn\/72.1.257S","journal-title":"Am J Clin Nutr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/71.5.1280s","article-title":"Anemia and iron deficiency: effects on pregnancy outcome","volume":"71","author":"Allen LH","year":"2000","unstructured":"Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr. 2000, 71:1280S-4S. 10.1093\/ajcn\/71.5.1280s","journal-title":"Am J Clin Nutr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-011-1381-2","article-title":"Postpartum anemia II: prevention and treatment","volume":"91","author":"Milman N","year":"2012","unstructured":"Milman N. Postpartum anemia II: prevention and treatment. Ann Hematol. 2012, 91:143-54. 10.1007\/s00277-011-1381-2","journal-title":"Ann Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2000.11746526","article-title":"Serum ferritin is a reliable, non-invasive test for iron status in pregnancy: comparison of ferritin with other iron status markers in a longitudinal study on healthy pregnant women","volume":"5","author":"Byg KE","year":"2000","unstructured":"Byg KE, Milman N, Hansen S, Agger AO. Serum ferritin is a reliable, non-invasive test for iron status in pregnancy: comparison of ferritin with other iron status markers in a longitudinal study on healthy pregnant women. Hematology. 2000, 5:319-25. 10.1080\/10245332.2000.11746526","journal-title":"Hematology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020447","article-title":"Iron deficiency and iron deficiency anemia: implications and impact in pregnancy, fetal development, and early childhood parameters","volume":"12","author":"Means RT","year":"2020","unstructured":"Means RT. Iron deficiency and iron deficiency anemia: implications and impact in pregnancy, fetal development, and early childhood parameters. Nutrients. 2020, 12:447. 10.3390\/nu12020447","journal-title":"Nutrients"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-672246","article-title":"How I treat anemia in pregnancy: iron, cobalamin, and folate","volume":"129","author":"Achebe MM","year":"2017","unstructured":"Achebe MM, Gafter-Gvili A. How I treat anemia in pregnancy: iron, cobalamin, and folate. Blood. 2017, 129:940-9. 10.1182\/blood-2016-08-672246","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4274\/tjod.01700","article-title":"Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report","volume":"12","author":"Api O","year":"2015","unstructured":"Api O, Breyman C, \u00c7etiner M, Demir C, Ecder T. Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report. Turk J Obstet Gynecol. 2015, 12:173-81. 10.4274\/tjod.01700","journal-title":"Turk J Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.10.007","article-title":"The safety of intravenous iron preparations: systematic review and meta-analysis","volume":"90","author":"Avni T","year":"2015","unstructured":"Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015, 90:12-23. 10.1016\/j.mayocp.2014.10.007","journal-title":"Mayo Clin Proc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi253","article-title":"Update on adverse drug events associated with parenteral iron","volume":"21","author":"Chertow GM","year":"2006","unstructured":"Chertow GM, Mason PD, Vaage-Nilsen O, Ahlm\u00e9n J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant. 2006, 21:378-82. 10.1093\/ndt\/gfi253","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1515\/jpm-2016-0050","article-title":"Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP)","volume":"45","author":"Breymann C","year":"2017","unstructured":"Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med. 2017, 45:443-5. 10.1515\/jpm-2016-0050","journal-title":"J Perinat Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60689-8","article-title":"Clinical update: intravenous iron for anaemia","volume":"369","author":"Auerbach M","year":"2007","unstructured":"Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet. 2007, 369:1502-1504. 10.1016\/S0140-6736(07)60689-8","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-14-115","article-title":"Intravenous ferric carboxymaltose for anaemia in pregnancy","volume":"14","author":"Froessler B","year":"2014","unstructured":"Froessler B, Collingwood J, Hodyl NA, Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth. 2014, 14:115. 10.1186\/1471-2393-14-115","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1515\/jpm-2011-0231","article-title":"Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose","volume":"40","author":"Christoph P","year":"2012","unstructured":"Christoph P, Schuller C, Studer H, et al.. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med. 2012, 40:469-74.","journal-title":"J Perinat Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06223.x","article-title":"Anemia in pregnancy","volume":"900","author":"Sifakis S","year":"2000","unstructured":"Sifakis S, Pharmakides G. Anemia in pregnancy. Ann N Y Acad Sci. 2000, 900:125-36. 10.1111\/j.1749-6632.2000.tb06223.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/nu7010153","article-title":"A review of the impact of dietary intakes in human pregnancy on infant birthweight","volume":"7","author":"Grieger JA","year":"2014","unstructured":"Grieger JA, Clifton VL. A review of the impact of dietary intakes in human pregnancy on infant birthweight. Nutrients. 2014, 7:153-78. 10.3390\/nu7010153","journal-title":"Nutrients"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4325647","article-title":"Severe vitamin B12 deficiency in pregnancy mimicking HELLP syndrome","volume":"2019","author":"Govindappagari S","year":"2019","unstructured":"Govindappagari S, Nguyen M, Gupta M, Hanna RM, Burwick RM. Severe vitamin B12 deficiency in pregnancy mimicking HELLP syndrome. Case Rep Obstet Gynecol. 2019, 2019:4325647. 10.1155\/2019\/4325647","journal-title":"Case Rep Obstet Gynecol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70172-6","article-title":"Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecology","volume":"14","author":"Frenkel EP","year":"2000","unstructured":"Frenkel EP, Yardley DA. Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecology. Hematol Oncol Clin North Am. 2000, 14:1079-1100. 10.1016\/S0889-8588(05)70172-6","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13574","article-title":"Should vitamin B12 status be considered in assessing risk of neural tube defects?","volume":"1414","author":"Molloy AM","year":"2018","unstructured":"Molloy AM. Should vitamin B12 status be considered in assessing risk of neural tube defects?. Ann N Y Acad Sci. 2018, 1414:109-25. 10.1111\/nyas.13574","journal-title":"Ann N Y Acad Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-199411000-00004","article-title":"Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency","volume":"308","author":"Matchar DB","year":"1994","unstructured":"Matchar DB, McCrory DC, Millington DS, Feussner JR. Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency. Am J Med Sci. 1994, 308:276-83. 10.1097\/00000441-199411000-00004","journal-title":"Am J Med Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-2199-9_16","article-title":"Cobalamin deficiency","volume":"56","author":"Herrmann W","year":"2012","unstructured":"Herrmann W, Obeid R. Cobalamin deficiency. Subcell Biochem. 2012, 56:301-22. 10.1007\/978-94-007-2199-9_16","journal-title":"Subcell Biochem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12959","article-title":"Guidelines for the diagnosis and treatment of cobalamin and folate disorders","volume":"166","author":"Devalia V","year":"2014","unstructured":"Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014, 166:496-513. 10.1111\/bjh.12959","journal-title":"Br J Haematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.12.924","article-title":"Red cell or serum folate? Results from the National Pathology Alliance benchmarking review","volume":"56","author":"Galloway M","year":"2003","unstructured":"Galloway M, Rushworth L. Red cell or serum folate? Results from the National Pathology Alliance benchmarking review. J Clin Pathol. 2003, 56:924-6. 10.1136\/jcp.56.12.924","journal-title":"J Clin Pathol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00009","article-title":"Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement","volume":"150","author":"U.S. Preventive Services Task Force","year":"2009","unstructured":"U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009, 150:626-31. 10.7326\/0003-4819-150-9-200905050-00009","journal-title":"Ann Intern Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038186","article-title":"Folic acid and the prevention of neural-tube defects","volume":"350","author":"Wald NJ","year":"2004","unstructured":"Wald NJ. Folic acid and the prevention of neural-tube defects. N Engl J Med. 2004, 350:101-3. 10.1056\/NEJMp038186","journal-title":"N Engl J Med"},{"key":"ref32","article-title":"Vitamin and Mineral Requirements in Human Nutrition","author":"World Health Organization and Food and Agriculture Organization of the United Nations","year":"2004","unstructured":"World Health Organization and Food and Agriculture Organization of the United Nations. Vitamin and Mineral Requirements in Human Nutrition. World Health Organization, Geneva, Switzerland; 2004."},{"key":"ref33","article-title":"Thrombocytopenia in pregnancy","volume":"15","author":"Levy JA","year":"2002","unstructured":"Levy JA, Murphy LD. Thrombocytopenia in pregnancy. J Am Board Fam Pract. 2002, 15:290-7.","journal-title":"J Am Board Fam Pract"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2019.1640870","article-title":"Managing ITP and thrombocytopenia in pregnancy","volume":"31","author":"Eslick R","year":"2020","unstructured":"Eslick R, McLintock C. Managing ITP and thrombocytopenia in pregnancy. Platelets. 2020, 31:300-6. 10.1080\/09537104.2019.1640870","journal-title":"Platelets"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4103\/1119-3077.195540","article-title":"Case of twin pregnancy complicated by idiopathic thrombocytopenic purpura treated with intravenous immunoglobulin: review of the literature","volume":"20","author":"Zhao WX","year":"2017","unstructured":"Zhao WX, Yang XF, Lin JH. Case of twin pregnancy complicated by idiopathic thrombocytopenic purpura treated with intravenous immunoglobulin: review of the literature. Niger J Clin Pract. 2017, 20:115-8. 10.4103\/1119-3077.195540","journal-title":"Niger J Clin Pract"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-013-2958-x","article-title":"Pregnancy outcome in patients with idiopathic thrombocytopenic purpura","volume":"289","author":"Subbaiah M","year":"2014","unstructured":"Subbaiah M, Kumar S, Roy KK, Sharma JB, Singh N. Pregnancy outcome in patients with idiopathic thrombocytopenic purpura. Arch Gynecol Obstet. 2014, 289:269-73. 10.1007\/s00404-013-2958-x","journal-title":"Arch Gynecol Obstet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","year":"2003","unstructured":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003, 120.574-96. 10.1046\/j.1365-2141.2003.04131.x","journal-title":"Br J Haematol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292005","article-title":"Fetal thrombocytopenia and its relation to maternal thrombocytopenia","volume":"329","author":"Burrows RF","year":"1993","unstructured":"Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993, 329:1463-6. 10.1056\/NEJM199311113292005","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan D","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, et al.. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010, 115:168-86. 10.1182\/blood-2009-06-225565","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470210","article-title":"Clinical relevance of gestational thrombocytopenia of <100,000\/\u03bcl","volume":"47","author":"Anteby E","year":"1994","unstructured":"Anteby E, Shalev O. Clinical relevance of gestational thrombocytopenia of &lt;100,000\/\u03bcl. Am J Hematol. 1994, 47:118-22. 10.1002\/ajh.2830470210","journal-title":"Am J Hematol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.397","article-title":"Thrombocytopenia in pregnancy","volume":"2010","author":"McCrae KR","year":"2010","unstructured":"McCrae KR. Thrombocytopenia in pregnancy. Hematology Am Soc Hematol Educ Program. 2010, 2010:397-402. 10.1182\/asheducation-2010.1.397","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan D","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, et al.. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010, 115:168-86. 10.1182\/blood-2009-06-225565","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.08.005","article-title":"Immune thrombocytopenia in pregnancy","volume":"23","author":"Stavrou E","year":"2009","unstructured":"Stavrou E, McCrae KR. Immune thrombocytopenia in pregnancy. Hematol Oncol Clin North Am. 2009, 23:1299-316. 10.1016\/j.hoc.2009.08.005","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-12-309153","article-title":"How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment","volume":"120","author":"Ghanima W","year":"2012","unstructured":"Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood. 2012, 120:960-9. 10.1182\/blood-2011-12-309153","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.007674","article-title":"Definition, diagnosis and treatment of immune thrombocytopenic purpura","volume":"94","author":"George JN","year":"2009","unstructured":"George JN. Definition, diagnosis and treatment of immune thrombocytopenic purpura. Haematologica. 2009, 94:759-62. 10.3324\/haematol.2009.007674","journal-title":"Haematologica"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)80030-5","article-title":"Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases","volume":"175","author":"Egerman RS","year":"1996","unstructured":"Egerman RS, Witlin AG, Friedman SA, Sibai BM. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases. Am J Obstet Gynecol. 1996, 175:950-6. 10.1016\/S0002-9378(96)80030-5","journal-title":"Am J Obstet Gynecol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan M","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M, et al.. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998, 339:1578-84. 10.1056\/NEJM199811263392202","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4490","article-title":"ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases","volume":"106","author":"Rieger M","year":"2005","unstructured":"Rieger M, Mannucci PM, Kremer Hovinga JA, et al.. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood. 2005, 106:1262-7. 10.1182\/blood-2004-11-4490","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully M","year":"2008","unstructured":"Scully M, Yarranton H, Liesner R, et al.. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol. 2008, 142:819-26. 10.1111\/j.1365-2141.2008.07276.x","journal-title":"Br J Haematol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.03.011","article-title":"Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006","volume":"120","author":"Ghanima W","year":"2012","unstructured":"Ghanima W, Godeau B, Cines DB, Bussel JB. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006. Blood. 2012, 120:960-9. 10.1016\/j.ajog.2008.03.011","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1331380","article-title":"Management of pregnancy-associated thrombotic thrombocytopenia purpura","volume":"3","author":"Fyfe-Brown A","year":"2013","unstructured":"Fyfe-Brown A, Clarke G, Nerenberg K, Chandra S, Jain V. Management of pregnancy-associated thrombotic thrombocytopenia purpura. AJP Rep. 2013, 3:45-50. 10.1055\/s-0032-1331380","journal-title":"AJP Rep"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1579539","article-title":"Pregnancy-associated atypical hemolytic-uremic syndrome","volume":"6","author":"Saad AF","year":"2016","unstructured":"Saad AF, Roman J, Wyble A, Pacheco LD. Pregnancy-associated atypical hemolytic-uremic syndrome. AJP Rep. 2016, 6:e125-8. 10.1055\/s-0036-1579539","journal-title":"AJP Rep"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(98)00031-3","article-title":"The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy","volume":"91","author":"Dashe JS","year":"1998","unstructured":"Dashe JS, Ramin SM, Cunningham FG.. The long-term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol. 1998, 91:662-8. 10.1016\/S0029-7844(98)00031-3","journal-title":"Obstet Gynecol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1159\/000337954","article-title":"Clinical grand rounds: atypical hemolytic uremic syndrome","volume":"35","author":"Hodgkins KS","year":"2012","unstructured":"Hodgkins KS, Bobrowski AE, Lane JC, Langman CB. Clinical grand rounds: atypical hemolytic uremic syndrome. Am J Nephrol. 2012, 35:394-400. 10.1159\/000337954","journal-title":"Am J Nephrol"},{"key":"ref55","article-title":"HELLP syndrome: recognition and perinatal management","volume":"60","author":"Padden MOH","year":"1999","unstructured":"Padden MOH. HELLP syndrome: recognition and perinatal management. Am Fam Physician. 1999, 60:829.","journal-title":"Am Fam Physician"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.5414\/cn107220","article-title":"Therapeutic regulation of complement in patients with renal disease - where is the promise?","volume":"77","author":"Thurman JM","year":"2012","unstructured":"Thurman JM. Therapeutic regulation of complement in patients with renal disease - where is the promise?. Clin Nephrol. 2012, 77:413-23. 10.5414\/cn107220","journal-title":"Clin Nephrol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli J","year":"2006","unstructured":"Caprioli J, Noris M, Brioschi S, et al.. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006, 108:1267-79. 10.1182\/blood-2005-10-007252","journal-title":"Blood"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e3283566af9","article-title":"Impact of inherited bleeding disorders on pregnancy and postpartum hemorrhage","volume":"23","author":"Shahbazi S","year":"2012","unstructured":"Shahbazi S, Moghaddam-Banaem L, Ekhtesari F, Ala FA. Impact of inherited bleeding disorders on pregnancy and postpartum hemorrhage. Blood Coagul Fibrinolysis. 2012, 23:603-7. 10.1097\/MBC.0b013e3283566af9","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler JE","year":"2003","unstructured":"Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood. 2003, 101:2089-93. 10.1182\/blood-2002-09-2892","journal-title":"Blood"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112736","article-title":"Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation","volume":"78","author":"Moake JL","year":"1986","unstructured":"Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 1986, 78:1456-61. 10.1172\/JCI112736","journal-title":"J Clin Invest"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01150.x","article-title":"von Willebrand disease and pregnancy","volume":"3","author":"Kujovich JL","year":"2005","unstructured":"Kujovich JL. von Willebrand disease and pregnancy. J Thromb Haemost. 2005, 3:246-53. 10.1111\/j.1538-7836.2005.01150.x","journal-title":"J Thromb Haemost"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James AH","year":"2007","unstructured":"James AH, Jamison MG. Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease. J Thromb Haemost. 2007, 5:1165-9. 10.1111\/j.1538-7836.2007.02563.x","journal-title":"J Thromb Haemost"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.077263","article-title":"Principles of care for the diagnosis and treatment of von Willebrand disease","volume":"98","author":"Castaman G","year":"2013","unstructured":"Castaman G, Goodeve A, Eikenboom J. Principles of care for the diagnosis and treatment of von Willebrand disease. Haematologica. 2013, 98:667-74. 10.3324\/haematol.2012.077263","journal-title":"Haematologica"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-153296","article-title":"How I treat von Willebrand disease","volume":"114","author":"Rodeghiero F","year":"2009","unstructured":"Rodeghiero F, Castaman G, Tosetto A. How I treat von Willebrand disease. Blood. 2009, 114:1158-65. 10.1182\/blood-2009-01-153296","journal-title":"Blood"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-498303","article-title":"von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy","volume":"122","author":"Lillicrap D","year":"2013","unstructured":"Lillicrap D. von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. Blood. 2013, 122:3735-40. 10.1182\/blood-2013-06-498303","journal-title":"Blood"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-40","article-title":"The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial","volume":"11","author":"Shakur H","year":"2010","unstructured":"Shakur H, Elbourne D, G\u00fclmezoglu M, Alfirevic Z, Ronsmans C, Allen E, Roberts I. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010, 11:40. 10.1186\/1745-6215-11-40","journal-title":"Trials"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2019.04.005","article-title":"Tranexamic acid for post-partum haemorrhage: what, who and when","volume":"61","author":"Brenner A","year":"2019","unstructured":"Brenner A, Ker K, Shakur-Still H, Roberts I. Tranexamic acid for post-partum haemorrhage: what, who and when. Best Pract Res Clin Obstet Gynaecol. 2019, 61:66-74. 10.1016\/j.bpobgyn.2019.04.005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-012-0175-6","article-title":"Physiological changes in hematological parameters during pregnancy","volume":"28","author":"Chandra S","year":"2012","unstructured":"Chandra S, Tripathi AK, Mishra S, Amzarul M, Vaish AK. Physiological changes in hematological parameters during pregnancy. Indian J Hematol Blood Transfus. 2012, 28:144-6. 10.1007\/s12288-012-0175-6","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1002\/bdrc.21111","article-title":"Nonclinical aspects of venous thrombosis in pregnancy","volume":"105","author":"Struble E","year":"2015","unstructured":"Struble E, Harrouk W, DeFelice A, Tesfamariam B. Nonclinical aspects of venous thrombosis in pregnancy. Birth Defects Res C Embryo Today. 2015, 105:190-20. 10.1002\/bdrc.21111","journal-title":"Birth Defects Res C Embryo Today"},{"key":"ref70","article-title":"Physiology, Postpartum Changes","author":"Chauhan G","unstructured":"Chauhan G, Tadi P. Physiology, Postpartum Changes. 2020 (ed): StatPearls Publishing, Treasure Island (FL);"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01877.x","article-title":"Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism","volume":"108","author":"McColl MD","year":"2000","unstructured":"McColl MD, Ellison J, Greer IA, Tait RC, Walker ID. Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol. 2000, 108:272-4. 10.1046\/j.1365-2141.2000.01877.x","journal-title":"Br J Haematol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.143","article-title":"Management of pregnant women with thrombophilia or a history of venous thromboembolism","volume":"2007","author":"Bates SM","year":"2007","unstructured":"Bates SM. Management of pregnant women with thrombophilia or a history of venous thromboembolism. Hematology Am Soc Hematol Educ Program. 2007, 2007:143-50. 10.1182\/asheducation-2007.1.143","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-0328(02)01525-2","article-title":"Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: case series","volume":"109","author":"Rodie VA","year":"2002","unstructured":"Rodie VA, Thomson AJ, Stewart FM, Quinn AJ, Walker ID, Greer IA. Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: case series. Br J Obstet Gynaecol. 2002, 109:1020-1024. 10.1016\/S1470-0328(02)01525-2","journal-title":"Br J Obstet Gynaecol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-015-0893-5","article-title":"Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre","volume":"105","author":"Hoeltzenbein M","year":"2016","unstructured":"Hoeltzenbein M, Beck E, Meixner K, Schaefer C, Kreutz R. Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre. Clin Res Cardiol. 2016, 105:117-26. 10.1007\/s00392-015-0893-5","journal-title":"Clin Res Cardiol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.15420\/icr.2020.06","article-title":"Management of valvular disease during pregnancy: evolving role of percutaneous treatment","volume":"15","author":"Fraccaro C","year":"2020","unstructured":"Fraccaro C, Tence N, Masiero G, Karam N. Management of valvular disease during pregnancy: evolving role of percutaneous treatment. Interv Cardiol. 2020, 15:e10. 10.15420\/icr.2020.06","journal-title":"Interv Cardiol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally GM","year":"2020","unstructured":"Arepally GM, Cines DB. Pathogenesis of heparin-induced thrombocytopenia. Transl Res. 2020, 225:131-40. 10.1016\/j.trsl.2020.04.014","journal-title":"Transl Res"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.03.012","article-title":"Diagnosis and management of heparin-induced thrombocytopenia","volume":"39","author":"Gruel Y","year":"2020","unstructured":"Gruel Y, De Maistre E, Pouplard C, et al.. Diagnosis and management of heparin-induced thrombocytopenia. Anaesth Crit Care Pain Med. 2020, 39:291-310. 10.1016\/j.accpm.2020.03.012","journal-title":"Anaesth Crit Care Pain Med"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.04.001","article-title":"Fondaparinux in pregnancy: could it be a safe option? A review of the literature","volume":"135","author":"De Carolis S","year":"2015","unstructured":"De Carolis S, di Pasquo E, Rossi E, et al.. Fondaparinux in pregnancy: could it be a safe option? A review of the literature. Thromb Res. 2015, 135:1049-51. 10.1016\/j.thromres.2015.04.001","journal-title":"Thromb Res"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23240","article-title":"Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry study","volume":"100","author":"Calzolari E","year":"2014","unstructured":"Calzolari E, Barisic I, Loane M, et al.. Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry study. Birth Defects Res A Clin Mol Teratol. 2014, 100:270-6. 10.1002\/bdra.23240","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23240","article-title":"Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry study","volume":"100","author":"Calzolari E","year":"2014","unstructured":"Calzolari E, Barisic I, Loane M, et al.. Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry study. Birth Defects Res A Clin Mol Teratol. 2014, 100:270-6. 10.1002\/bdra.23240","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-04-0305","article-title":"Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting","volume":"116","author":"Beyer-Westendorf J","year":"2016","unstructured":"Beyer-Westendorf J, Michalski F, Tittl L, et al.. Pregnancy outcome in patients exposed to direct oral anticoagulants - and the challenge of event reporting. Thromb Haemost. 2016, 116:651-8. 10.1160\/TH16-04-0305","journal-title":"Thromb Haemost"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/59605-hematologic-findings-in-pregnancy-a-guide-for-the-internist","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:05Z","timestamp":1707507245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/59605-hematologic-findings-in-pregnancy-a-guide-for-the-internist"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":81,"URL":"https:\/\/doi.org\/10.7759\/cureus.15149","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,21]]}}}